Edition:
United States

Rockwell Medical Inc (RMTI.OQ)

RMTI.OQ on NASDAQ Stock Exchange Global Market

5.83USD
3:59pm EST
Change (% chg)

$-0.17 (-2.83%)
Prev Close
$6.00
Open
$5.94
Day's High
$6.01
Day's Low
$5.74
Volume
61,235
Avg. Vol
91,290
52-wk High
$10.56
52-wk Low
$3.55

RMTI.OQ

Chart for RMTI.OQ

About

Rockwell Medical, Inc. (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves... (more)

Overall

Beta: 2.02
Market Cap(Mil.): $309.17
Shares Outstanding(Mil.): 51.53
Dividend: --
Yield (%): --

Financials

  RMTI.OQ Industry Sector
P/E (TTM): -- 28.39 29.32
EPS (TTM): -0.41 -- --
ROI: -25.98 13.54 13.03
ROE: -34.14 14.43 14.17

BRIEF-David Richmond reports 10.8 pct stake in Rockwell Medical

* David Richmond reports 10.8 percent stake in Rockwell Medical Inc as of Feb 20 - sec filing

9:29am EST

BRIEF-Rockwell Medical updates progress on Calcitriol commercial launch

* Rockwell Medical updates progress on calcitriol commercial launch

9:21am EST

BRIEF-Rockwell Medical reports Q3 loss per share $0.09

* Q3 loss per share $0.09 Source text for Eikon: Further company coverage:

Nov 07 2016

BRIEF-Rockwell Medical anticipates Calcitriol to be available in U.S. in approximately 45 days

* Anticipates Calcitriol will become commercially available in U.S. in approximately 45 days Source text for Eikon: Further company coverage:

Sep 22 2016

More From Around the Web

Competitors

Earnings vs. Estimates